PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

July 29, 2011 Issue 71 Vol. 2
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Pharma May Feel the Pain from Debt Ceiling Debate
As the White House and Congress battle the looming deadline to raise the country’s debt ceiling, what are the potential implications of the various debt-reduction proposals on the pharmaceutical industry? ...Read more

Can the iPad Save Pharma Sales?
In the conclusion of this Pharma Faceoff episode, the panel tackles the tricky questions: What kind of data are iPads collecting? What does physician adoption of iPhones and iPads mean for pharma? And, can iPads actually reverse the trend toward shrinking access? ...Click to Watch

Do Generics Win in Express Scripts/Medco Deal?
As a preferred generics supplier to Medco’s mail-order business, Novartis’ Sandoz division, should be waiting with bated breath—and champagne at the ready—for an FTC approval of Express Scripts’ proposed $29.1 billion acquisition of Medco ...Read More

PharmRep Direct Features

Community and Territory
Social networks can improve promotion effectiveness in your territory
Read more

Pfizer Brings Clinical Trials Home
Remote trial management promises to reshape pre and post-market clinical studies Read more

Making the Case for Training
Focusing on company training needs beyond sales and marketing can maximize the training department’s ROI Read more

 
FindPharma   Search
 
Subscribe To PharmRep Today!
 
PharmRep Direct Quick Links
Uncle Sam wants you to reduce spending

FDA fuels Indian crackdown on substandard medicines

AIDS drug discounts threatened

Follow Pharm Rep on Twitter

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA
.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!